Pennsylvania Patent of the Month – March 2025
Lifeware Labs has introduced a groundbreaking wearable device that administers medications through a digitally controlled microneedle array. This innovation promises to transform chronic disease management and emergency care.
Precision Drug Delivery via Light-Activated Microneedles
The device, detailed in U.S. Patent No. 12,239,810 titled “Wearable apparatus containing a digitally controlled degradeable microneedle array for intradermal drug delivery,” features solid microneedles embedded with medication and a light-to-heat transducing element. Upon activation by an integrated light source, the microneedles release the drug into the skin. This mechanism allows for precise, on-demand dosing.
A key innovation is the device’s closed-loop control system. It can monitor physiological signals—such as heart rate or body temperature—and trigger drug release accordingly. This responsiveness enables real-time treatment adjustments, enhancing patient care.
Advancing Healthcare Accessibility and Efficiency
Lifeware Labs’ technology offers significant benefits for patients requiring regular medication, such as those with diabetes or cardiovascular conditions. By eliminating the need for manual injections, it reduces discomfort and the potential for dosing errors. The device’s compact design ensures ease of use in various settings, from hospitals to remote locations.
This innovation exemplifies the potential of integrating wearable technology with responsive drug delivery systems, marking a significant step forward in personalized medicine.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
